These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3004413)

  • 61. Effect of divalent cations on the binding of 3,5,3'-triiodothyronine to isolated rat liver nuclei.
    Rodriguez-Peña A; Bernal J
    Endocrinology; 1982 Jan; 110(1):246-53. PubMed ID: 6274620
    [No Abstract]   [Full Text] [Related]  

  • 62. Evidence for an active step in thyroid hormone transport to nuclei: drug inhibition of L-125I-triiodothyronine binding to nuclear receptors in rat pituitary tumor cells.
    Halpern J; Hinkle PM
    Endocrinology; 1982 Mar; 110(3):1070-2. PubMed ID: 6276153
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Increase in 3,5,3'-triiodothyronine (T3)-binding sites in tadpole erythrocyte nuclei during spontaneous and T3-induced metamorphosis.
    Moriya T; Thomas CR; Frieden E
    Endocrinology; 1984 Jan; 114(1):170-5. PubMed ID: 6317343
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Thyroid hormone receptor occupancy and biological effects of 3,5,3,-L-triiodothyronine (T3) in GH4C1 rat pituitary tumour cells.
    Filipcík P; Strbák V; Brtko J
    Physiol Res; 1998; 47(1):41-6. PubMed ID: 9708700
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Solubilized nuclear thyroid hormone receptors in circulating human mononuclear cells.
    Burman KD; Latham KR; Djuh YY; Smallridge RC; Tseng YC; Lukes YG; Maunder R; Wartofsky L
    J Clin Endocrinol Metab; 1980 Jul; 51(1):106-16. PubMed ID: 6247359
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Comparative study of pituitary-thyroid hormone economy in fasting and hypothyroid rats.
    St Germain DL; Galton VA
    J Clin Invest; 1985 Feb; 75(2):679-88. PubMed ID: 2982916
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Reduced triiodothyronine content in liver but not pituitary of the uremic rat model: demonstration of changes compatible with thyroid hormone deficiency in liver only.
    Lim VS; Passo C; Murata Y; Ferrari E; Nakamura H; Refetoff S
    Endocrinology; 1984 Jan; 114(1):280-6. PubMed ID: 6317348
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Studies of nuclear 3,5,3'-triiodothyronine binding in primary cultures of rat brain.
    Kolodny JM; Leonard JL; Larsen PR; Silva JE
    Endocrinology; 1985 Nov; 117(5):1848-57. PubMed ID: 2994999
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The contribution of local tissue thyroxine monodeiodination to the nuclear 3,5,3'-triiodothyronine in pituitary, liver, and kidney of euthyroid rats.
    Silva JE; Dick TE; Larsen PR
    Endocrinology; 1978 Oct; 103(4):1196-207. PubMed ID: 217671
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Chromatin receptors for thyroid hormones. Interactions of the solubilized proteins with DNA.
    MacLeod KM; Baxter JD
    J Biol Chem; 1976 Dec; 251(23):7380-7. PubMed ID: 187584
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Short-term changes in the 3,5,3'-tri-iodothyronine nuclear receptor-binding capacity of porcine skeletal muscle following food intake.
    Morovat A; Dauncey MJ
    J Endocrinol; 1992 Jul; 134(1):67-72. PubMed ID: 1500845
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Purification of chick nuclear thyroid-hormone-receptor protein.
    Heintz JF; Carew LB; Murnane A; Heintz RL
    Eur J Biochem; 1984 Mar; 139(3):613-7. PubMed ID: 6321182
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Stability of nuclear thyroid-hormone receptor and its behavior on hydroxylapatite.
    Yoshizato K
    Mol Cell Endocrinol; 1980 Jul; 19(1):69-77. PubMed ID: 6248404
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Binding of selected iodothyronine analogues to receptor sites of isolated rat hepatic nuclei. High correlation between structural requirements for nuclear binding and biological activity.
    Koerner D; Schwartz HL; Surks MI; Oppenheimer JH
    J Biol Chem; 1975 Aug; 250(16):6417-23. PubMed ID: 169242
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Site-specific basicities regulate molecular recognition in receptor binding: in silico docking of thyroid hormones.
    Tóth G; Baska F; Schretner A; Rácz A; Noszál B
    Eur Biophys J; 2013 Sep; 42(9):721-30. PubMed ID: 23907234
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effects of pH and ionic strength on the binding of L-tri-iodothyronine to the solubilized nuclear receptor.
    Wilson BD; Gent WL
    Biochem J; 1985 Dec; 232(3):663-7. PubMed ID: 3004413
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sequential changes in rat liver nuclear tri-iodothyronine receptors and mitochondrial alpha-glycerophosphate dehydrogenase activity after administration of tri-iodothyronine.
    Nakamura H; Hamada S; Imura H
    Biochem J; 1979 Aug; 182(2):377-82. PubMed ID: 228652
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A new unextracted-sample radioimmunoassay method for hepatic endogenous nuclear L-tri-iodothyronine content. Validity of its use in determining nuclear receptor binding characteristics.
    Yagura T; Walfish PG
    Biochem J; 1982 Dec; 208(3):641-9. PubMed ID: 6299277
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Experimental values of the ionization constants for L-3,5-di-iodotyrosine and a model for ionic interactions of thyroid hormone (T3) and its nuclear receptor.
    Gent WL; Wilson BD
    Biochem Pharmacol; 1989 Jan; 38(2):343-6. PubMed ID: 2914019
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interactions of the nuclear thyroid hormone receptor with core histones.
    Apriletti JW; David-Inouye Y; Eberhardt NL; Baxter JD
    J Biol Chem; 1984 Sep; 259(17):10941-8. PubMed ID: 6088522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.